Cargando…
Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection
Traumatic spinal cord injury (SCI) causes dramatic disability and dysfunction in the motor, sensory and autonomic systems. The severe inflammatory reaction that occurs after SCI is strongly associated with further tissue damage. As such, immunomodulatory strategies have been developed, aimed at redu...
Autores principales: | Lima, Rui, Monteiro, Susana, Lopes, José P., Barradas, Pedro, Vasconcelos, Natália L., Gomes, Eduardo D., Assunção-Silva, Rita C., Teixeira, Fábio G., Morais, Mónica, Sousa, Nuno, Salgado, António J., Silva, Nuno A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748640/ https://www.ncbi.nlm.nih.gov/pubmed/29064422 http://dx.doi.org/10.3390/ph10040083 |
Ejemplares similares
-
Citalopram Administration Does Not Promote Function or Histological Recovery after Spinal Cord Injury
por: Lima, Rui, et al.
Publicado: (2020) -
Immunomodulation as a neuroprotective strategy after spinal cord injury
por: Monteiro, Susana, et al.
Publicado: (2018) -
Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration
por: Assunção-Silva, Rita C., et al.
Publicado: (2015) -
Pathophysiology and Therapeutic Approaches for Spinal Cord Injury
por: Lima, Rui, et al.
Publicado: (2022) -
Levetiracetam treatment leads to functional recovery after thoracic or cervical injuries of the spinal cord
por: Lima, Rui, et al.
Publicado: (2021)